499O - Phase Ii Study of First-Line Mfolfox Plus Cetuximab (C) for 8 Cycles Followed By Mfolfox Plus C or Single Agent (S/A) C As Maintenance Therapy in Patients (P) with Metastatic Colorectal Cancer (Mcrc): the Macro-2 Trial (Spanish Cooperative Group for the Treatment of Digestive Tumors [Ttd])
| Autor: | Alfonso, P. García, Benavides, M., Ruiz, A. Sánchez, Guillen-Ponce, C., Safont, M.J., Alcaide, J., Gómez, A., Lopez, R., Manzano, J.L., Urena, M. Mendez, Rivera, F., Sastre, J., Grávalos, C., García, T. García, Martin-Valades, J.I., Falco, E., Flores, E. González, Navalón, M., Rubio, E. Diaz, Aranda, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2014 25 Supplement 4:iv168-iv168 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|